ATC code P01
| ATC codes |
|---|
| P Antiparasitic products, insecticides and repellents |
| Human only |
| P01 Antiprotozoals |
| P02 Anthelmintics |
| P03 Ectoparasiticides, including scabicides, insecticides and repellents |
| ATCvet only |
| QP51 Antiprotozoals |
| QP52 Anthelmintics |
| QP53 Ectoparasiticides, including insecticides and repellents |
| QP54 Endectocides |
|
|
ATC code P01 Antiprotozoals is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup P01 is part of the anatomical group P Antiparasitic products, insecticides and repellents.[4]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
P01A Agents against amoebiasis and other protozoal diseases
P01AA Hydroxyquinoline derivatives
- P01AA01 Broxyquinoline
- P01AA02 Clioquinol
- P01AA04 Chlorquinaldol
- P01AA05 Tilbroquinol
- P01AA30 Tilbroquinol and tiliquinol
- P01AA52 Clioquinol, combinations
P01AB Nitroimidazole derivatives
- P01AB01 Metronidazole
- P01AB02 Tinidazole
- P01AB03 Ornidazole
- P01AB04 Azanidazole
- P01AB05 Propenidazole
- P01AB06 Nimorazole
- P01AB07 Secnidazole
- P01AB51 Metronidazole and furazolidone
- P01AB52 Metronidazole and diloxanide
P01AC Dichloroacetamide derivatives
- P01AC01 Diloxanide
- P01AC02 Clefamide
- P01AC03 Etofamide
- P01AC04 Teclozan
P01AR Arsenic compounds
- P01AR01 Arsthinol
- P01AR02 Difetarsone
- P01AR03 Glycobiarsol
- P01AR53 Glycobiarsol, combinations
P01AX Other agents against amoebiasis and other protozoal diseases
- P01AX01 Chiniofon
- P01AX02 Emetine
- P01AX04 Phanquinone
- P01AX05 Mepacrine
- P01AX06 Atovaquone
- P01AX07 Trimetrexate
- P01AX08 Tenonitrozole
- P01AX09 Dehydroemetine
- P01AX10 Fumagillin
- P01AX11 Nitazoxanide
- P01AX52 Emetine, combinations
P01B Antimalarials
P01BA Aminoquinolines
- P01BA01 Chloroquine
- P01BA02 Hydroxychloroquine
- P01BA03 Primaquine
- P01BA06 Amodiaquine
- P01BA07 Tafenoquine
P01BB Biguanides
- P01BB01 Proguanil
- P01BB02 Cycloguanil embonate
- P01BB51 Proguanil and atovaquone
- P01BB52 Chloroquine and proguanil
P01BC Methanolquinolines
- P01BC01 Quinine
- P01BC02 Mefloquine
P01BD Diaminopyrimidines
- P01BD01 Pyrimethamine
- P01BD51 Pyrimethamine, combinations
P01BE Artemisinin and derivatives, plain
- P01BE01 Artemisinin
- P01BE02 Artemether
- P01BE03 Artesunate
- P01BE04 Artemotil
- P01BE05 Artenimol
P01BF Artemisinin and derivatives, combinations
- P01BF01 Artemether and lumefantrine
- P01BF02 Artesunate and mefloquine
- P01BF03 Artesunate and amodiaquine
- P01BF04 Artesunate, sulfalene and pyrimethamine
- P01BF05 Artenimol and piperaquine
- P01BF06 Artesunate and pyronaridine
- P01BF07 Artemisinin and piperaquine
- P01BF08 Artemisinin and naphthoquine
- P01BF09 Artesunate, sulfadoxine and pyrimethamine
P01BX Other antimalarials
- P01BX01 Halofantrine
- P01BX02 Arterolane and piperaquine
P01C Agents against leishmaniasis and trypanosomiasis
P01CA Nitroimidazole derivatives
- P01CA02 Benznidazole
- P01CA03 Fexinidazole
P01CB Antimony compounds
- P01CB01 Meglumine antimonate
- P01CB02 Sodium stibogluconate
P01CC Nitrofuran derivatives
- P01CC01 Nifurtimox
- P01CC02 Nitrofural
P01CD Arsenic compounds
- P01CD01 Melarsoprol
- P01CD02 Acetarsol
P01CX Other agents against leishmaniasis and trypanosomiasis
- P01CX01 Pentamidine isethionate
- P01CX02 Suramin sodium
- P01CX03 Eflornithine
- P01CX04 Miltefosine
References
- ↑ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
- ↑ World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
- ↑ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
- ↑ "ATC/DDD Index 2022: code P01". WHO Collaborating Centre for Drug Statistics Methodology.
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.